In-Vivo CRO

A Global Strategic Business Report

MCP33985

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7091

EXECUTIVE POOL

5850

PRICE

899

EXPERT INPUTS

39

COMPANIES

318

DATA TABLES

387

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global In-Vivo CRO Market to Reach US$7.2 Billion by 2030

The global market for In-Vivo CRO estimated at US$4.6 Billion in the year 2024, is expected to reach US$7.2 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Small Molecules, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth in the Large Molecules segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 12.4% CAGR

The In-Vivo CRO market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 12.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global In-Vivo CRO Market – Key Trends & Drivers Summarized

Why Are In-Vivo CRO Services Gaining Strategic Importance in Drug Development?
In-vivo contract research organizations (CROs) play a critical role in the pharmaceutical and biotechnology industries by providing outsourced preclinical and early-stage research services involving live animal models. These studies are essential to evaluate the pharmacokinetics, pharmacodynamics, efficacy, and safety of drug candidates before progressing to human trials. As regulatory scrutiny and drug development costs rise, sponsors are increasingly turning to specialized in-vivo CROs for their technical expertise, regulatory knowledge, and capacity to accelerate timelines while ensuring scientific rigor.

The rising complexity of therapeutics—including biologics, gene therapies, and personalized medicines—requires more sophisticated animal testing protocols that many in-house facilities cannot adequately support. In-vivo CROs offer customized study designs, validated models for specific disease indications, and advanced imaging and telemetry capabilities. Their ability to manage genetically engineered animal models, conduct toxicology studies, and support investigational new drug (IND) submissions makes them indispensable partners in preclinical research pipelines.

How Are Technology and Specialization Advancing the Capabilities of In-Vivo CROs?
Technological innovation is reshaping the landscape of in-vivo research services, enabling CROs to deliver higher accuracy, reproducibility, and insight into complex biological responses. Real-time imaging technologies such as MRI, PET, and optical imaging allow for non-invasive monitoring of disease progression and therapeutic impact. Advanced telemetry systems enable continuous measurement of vital signs, behavioral changes, and physiological parameters, reducing the number of animals required while improving data quality.

CROs are also expanding their portfolios to include specialized disease models—such as oncology, autoimmune disorders, rare diseases, and CNS pathologies—tailored to meet the evolving needs of biopharma companies. The development of humanized mouse models and transgenic strains has made it possible to conduct more translational research, bridging the gap between animal and human responses. Integration of digital lab notebooks, automated data capture systems, and AI-based data analysis tools is further increasing operational efficiency and scientific accuracy across in-vivo studies.

Which Segments and Regions Are Driving the Expansion of the In-Vivo CRO Market?
Pharmaceutical and biotechnology companies are the primary clients fueling demand for in-vivo CRO services, especially mid-size and emerging biotech firms that rely heavily on external partners due to limited internal R&D infrastructure. Increasing demand is also seen from academic research institutions and government-sponsored initiatives focused on translational medicine, vaccine development, and rare disease research. The oncology and CNS therapeutic areas represent the largest application segments, owing to the extensive animal modeling required to study tumor behavior and neurological functions.

North America dominates the global in-vivo CRO market, supported by a robust biopharmaceutical R&D ecosystem, established regulatory frameworks, and a high concentration of contract research infrastructure. Europe follows closely, with strong demand across Germany, the UK, and France. Asia-Pacific is emerging as a high-growth region, led by China and India, where cost advantages, regulatory reforms, and expanding local biopharma sectors are attracting outsourcing activity. Additionally, growing interest in ethical animal research and adherence to Good Laboratory Practice (GLP) standards in these regions is helping align local CROs with global clients’ expectations.

The Growth in the In-Vivo CRO Market Is Driven by Several Factors…
It is driven by the increasing complexity of drug candidates, which necessitates advanced animal modeling to evaluate safety and efficacy prior to clinical trials. Biopharmaceutical companies are increasingly outsourcing in-vivo studies to reduce fixed R&D costs, access specialized expertise, and accelerate timelines in competitive therapeutic areas. The expanding pipeline of biologics, cell and gene therapies, and novel delivery systems further amplifies the need for sophisticated in-vivo capabilities that can simulate human-like responses.

In parallel, advances in non-invasive imaging, telemetry, and disease model customization are enhancing the value proposition of in-vivo CROs, making them strategic partners in early-stage decision-making. Regulatory emphasis on well-documented, ethically conducted animal studies—especially for IND filings—continues to reinforce the importance of standardized, GLP-compliant service providers. Furthermore, the increasing demand for personalized and orphan drugs is creating a need for more targeted and adaptable in-vivo studies. These combined factors are ensuring steady and sustained growth of the in-vivo CRO market as a critical enabler of modern drug discovery and development.

SCOPE OF STUDY

The report analyzes the In-Vivo CRO market by the following Segments, and Geographic Regions/Countries:

Segments:

Type of Molecule (Small Molecules, Large Molecules); Therapeutic Area (Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions, Other Therapeutic Areas); Service Type (Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services, Other Service Types).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Biocytogen; Charles River Laboratories; Clinipace (Caidya); Covance Inc.; Crown Bioscience; Eurofins Scientific; Evotec SE; GemPharmatech Co., Ltd.; ICON plc; IQVIA Inc.; Janvier Labs; Labcorp Drug Development; Parexel International Corporation; Pharmaceutical Product Development (PPD); PsychoGenics Inc.; Syneos Health; Taconic Biosciences, Inc.; The Jackson Laboratory; Thermo Fisher Scientific Inc.; WuXi AppTec

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

World Market Trajectories

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

In-Vivo CRO – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 39 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Complexity of Preclinical Studies Drives Outsourcing to Specialized In-Vivo CROs

Increased Biotech and Pharma R&D Investments Spur Demand for In-Vivo Efficacy and Safety Studies

Growth in Oncology and Rare Disease Research Expands Need for Customized Animal Models

Regulatory Emphasis on Early Toxicology Screening Strengthens Role of In-Vivo Testing Services

Advancements in Imaging and Biomarker Analysis Enhance Precision in In-Vivo Study Design

Use of Humanized and Transgenic Animal Models Expands Market Scope for In-Vivo CRO Providers

Shift Toward Accelerated Drug Discovery Timelines Boosts Demand for End-to-End In-Vivo Capabilities

Collaborative Academic-Industry Research Models Fuel Outsourcing of Specialized In-Vivo Tasks

Increased Preclinical Activity in Cell and Gene Therapies Spurs Need for Complex In-Vivo Platforms

Integration of Digital Tools and Real-Time Monitoring Enhances Efficiency in In-Vivo Study Execution

Rising Demand for GLP-Compliant Facilities Drives Infrastructure Investments in Preclinical CROs

Geographic Expansion of CRO Operations Supports Global Trial Consistency and Regulatory Access

Growing Focus on Predictive In-Vivo Toxicology Solutions Reduces Late-Stage Clinical Trial Failures

4. GLOBAL MARKET PERSPECTIVE

World In-Vivo CRO Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for In-Vivo CRO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for In-Vivo CRO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for In-Vivo CRO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Small Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Large Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Large Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Large Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Preclinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Preclinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Preclinical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Clinical Research Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Clinical Research Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Clinical Research Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Consulting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Consulting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Consulting Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Autoimmune / Inflammation Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Autoimmune / Inflammation Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Autoimmune / Inflammation Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for CNS Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for CNS Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for CNS Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

JAPAN

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

CHINA

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

EUROPE

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for In-Vivo CRO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for In-Vivo CRO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for In-Vivo CRO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

FRANCE

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

GERMANY

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

UNITED KINGDOM

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

ASIA-PACIFIC

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for In-Vivo CRO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for In-Vivo CRO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for In-Vivo CRO by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

AUSTRALIA

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

INDIA

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

LATIN AMERICA

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for In-Vivo CRO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America Historic Review for In-Vivo CRO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for In-Vivo CRO by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

MIDDLE EAST

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for In-Vivo CRO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East Historic Review for In-Vivo CRO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for In-Vivo CRO by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

AFRICA

In-Vivo CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for In-Vivo CRO by Type of Molecule - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for In-Vivo CRO by Type of Molecule - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for In-Vivo CRO by Service Type - Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for In-Vivo CRO by Service Type - Percentage Breakdown of Value Sales for Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services and Other Service Types for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for In-Vivo CRO by Therapeutic Area - Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for In-Vivo CRO by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Cardiology, Diabetes, Autoimmune / Inflammation Conditions, Infectious Diseases, CNS Conditions and Other Therapeutic Areas for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Clinical Laboratories Pty Limited	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll